Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Five-year longitudinal assessment (2008 to 2012) of E-101 solution activity against clinical target and antimicrobial-resistant pathogens.

Denys GA, Pillar CM, Sahm DF, O'Hanley P, Stephens JT Jr.

Antimicrob Agents Chemother. 2014 Aug;58(8):4911-4. doi: 10.1128/AAC.03020-14. Epub 2014 May 19.

2.

In vitro and in vivo activities of E-101 solution against Acinetobacter baumannii isolates from U.S. military personnel.

Denys GA, Davis JC, O'Hanley PD, Stephens JT Jr.

Antimicrob Agents Chemother. 2011 Jul;55(7):3603-8. doi: 10.1128/AAC.01606-10. Epub 2011 Apr 25.

3.

In vitro antibacterial activity of E-101 Solution, a novel myeloperoxidase-mediated antimicrobial, against Gram-positive and Gram-negative pathogens.

Denys GA, Grover P, O'Hanley P, Stephens JT Jr.

J Antimicrob Chemother. 2011 Feb;66(2):335-42. doi: 10.1093/jac/dkq429. Epub 2010 Nov 30.

PMID:
21118915
4.

Virus-specific antiviral treatment for controlling severe and fatal outbreaks of feline calicivirus infection.

Smith AW, Iversen PL, O'Hanley PD, Skilling DE, Christensen JR, Weaver SS, Longley K, Stone MA, Poet SE, Matson DO.

Am J Vet Res. 2008 Jan;69(1):23-32. doi: 10.2460/ajvr.69.1.23.

PMID:
18167083
5.

First human experience with local delivery of novel antisense AVI-4126 with Infiltrator catheter in de novo native and restenotic coronary arteries: 6-month clinical and angiographic follow-up from AVAIL study.

Kipshidze N, Iversen P, Overlie P, Dunlap T, Titus B, Lee D, Moses J, O'Hanley P, Lauer M, Leon MB.

Cardiovasc Revasc Med. 2007 Oct-Dec;8(4):230-5.

PMID:
18053943
6.

Telephone triage: the quiet revolution in Canada.

O'Hanley P.

Telemed J E Health. 2004 Spring;10(1):109-11.

PMID:
15104923
7.

Telehealth: is it safe?

O'Hanley P, MacLean S, St-Martin M.

CMAJ. 2002 Sep 3;167(5):449. No abstract available.

8.

Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area.

Richie EE, Punjabi NH, Sidharta YY, Peetosutan KK, Sukandar MM, Wasserman SS, Lesmana MM, Wangsasaputra FF, Pandam SS, Levine MM, O'Hanley PP, Cryz SJ, Simanjuntak CH.

Vaccine. 2000 May 8;18(22):2399-410.

PMID:
10738097
9.

Topical tetracycline: potential for allergic reaction or bacterial resistance.

Encarnacion M, Waxman D, Wright J, O'Hanley P.

Compend Contin Educ Dent. 1997 Apr;18(4):325-6, 328, 330 passim; quiz 336. Review.

PMID:
9452541
10.

Triage through technology: New Brunswick Tele-Care service reduces ER visits.

O'Hanley P.

Hosp Q. 1997-1998 Winter;1(2):46-7. No abstract available.

PMID:
10345291
11.

Enterotoxigenic Escherichia coli diarrhea in children less than five years of age in central Java.

Orndorff GR, Sadjimin T, Simanjuntak CH, O'Hanley P, Punjabi NH, Tjokrosonto S, Corwin A, Dibley M, Lebron CI, Echeverria P.

Am J Trop Med Hyg. 1996 Oct;55(4):449-51.

PMID:
8916806
12.

Molecular characterization of Vibrio cholerae O139 isolates from Asia.

Echeverria P, Hoge CW, Bodhidatta L, Serichantalergs O, Dalsgaard A, Eampokalap B, Perrault J, Pazzaglia G, O'Hanley P, English C.

Am J Trop Med Hyg. 1995 Feb;52(2):124-7.

PMID:
7872438
13.

Antimicrobial susceptibilities of Neisseria gonorrhoeae strains isolated in Surabaya, Indonesia.

Joesoef MR, Knapp JS, Idajadi A, Linnan M, Barakbah Y, Kamboji A, O'Hanley P, Moran JS.

Antimicrob Agents Chemother. 1994 Nov;38(11):2530-3.

14.
16.

Safety, immunogenicity, and transmissibility of single-dose live oral cholera vaccine strain CVD 103-HgR in 24- to 59-month-old Indonesian children.

Simanjuntak CH, O'Hanley P, Punjabi NH, Noriega F, Pazzaglia G, Dykstra P, Kay B, Suharyono, Budiarso A, Rifai AR, et al.

J Infect Dis. 1993 Nov;168(5):1169-76.

PMID:
8228350
19.

Pharmacokinetics of zidovudine alone and in combination with oxazepam in the HIV infected patient.

Mole L, Israelski D, Bubp J, O'Hanley P, Merigan T, Blaschke T.

J Acquir Immune Defic Syndr. 1993 Jan;6(1):56-60.

PMID:
8417175
21.

Local cytokine production in a murine model of Escherichia coli pyelonephritis.

Rugo HS, O'Hanley P, Bishop AG, Pearce MK, Abrams JS, Howard M, O'Garra A.

J Clin Invest. 1992 Mar;89(3):1032-9.

22.

Affinity purification of functional receptors for Escherichia coli heat-stable enterotoxin from rat intestine.

Hugues M, Crane MR, Thomas BR, Robertson D, Gazzano H, O'Hanley P, Waldman SA.

Biochemistry. 1992 Jan 14;31(1):12-6.

PMID:
1310026
23.

Extended stability of ganciclovir for outpatient parenteral therapy for cytomegalovirus retinitis.

Mole L, Oliva C, O'Hanley P.

J Acquir Immune Defic Syndr. 1992;5(4):354-8.

PMID:
1312595
24.
25.

DNA sequences of three papA genes from uropathogenic Escherichia coli strains: evidence of structural and serological conservation.

Denich K, Blyn LB, Craiu A, Braaten BA, Hardy J, Low DA, O'Hanley PD.

Infect Immun. 1991 Nov;59(11):3849-58.

27.
28.
30.

Efficacy and cost-effectiveness of antibiotic monitoring at a Veterans Administration hospital.

O'Hanley P, Rodondi L, Coleman R.

Chemotherapy. 1991;37 Suppl 3:22-5.

PMID:
1909229
32.

Rat intestinal cell atrial natriuretic peptide receptor coupled to guanylate cyclase.

Crane MR, O'Hanley P, Waldman SA.

Gastroenterology. 1990 Jul;99(1):125-31.

PMID:
1971606
33.

Heterogeneity of intestinal receptors for Escherichia coli heat-stable enterotoxin.

Ivens K, Gazzano H, O'Hanley P, Waldman SA.

Infect Immun. 1990 Jun;58(6):1817-20.

34.
35.

Prevention of interleukin 2-induced acute lung injury in guinea pigs by pentoxifylline.

Ishizaka A, Hatherill JR, Harada H, Yonemaru M, Hoffmann H, Zheng H, O'Hanley PT, Raffin TA.

J Appl Physiol (1985). 1989 Dec;67(6):2432-7.

PMID:
2606851
36.
37.

Transformation of Actinobacillus pleuropneumoniae and analysis of R factors by electroporation.

Lalonde G, Miller JF, Tompkins LS, O'Hanley P.

Am J Vet Res. 1989 Nov;50(11):1957-60.

PMID:
2619125
38.

The effects of aminophylline and pentoxifylline on multiple organ damage after Escherichia coli sepsis.

Harada H, Ishizaka A, Yonemaru M, Mallick AA, Hatherill JR, Zheng H, Lilly CM, O'Hanley PT, Raffin TA.

Am Rev Respir Dis. 1989 Oct;140(4):974-80.

PMID:
2529804
39.

Stool diagnosis of giardiasis using a commercially available enzyme immunoassay to detect Giardia-specific antigen 65 (GSA 65).

Rosoff JD, Sanders CA, Sonnad SS, De Lay PR, Hadley WK, Vincenzi FF, Yajko DM, O'Hanley PD.

J Clin Microbiol. 1989 Sep;27(9):1997-2002.

40.
43.

Pentoxifylline prevents tumor necrosis factor-induced lung injury.

Lilly CM, Sandhu JS, Ishizaka A, Harada H, Yonemaru M, Larrick JW, Shi TX, O'Hanley PT, Raffin TA.

Am Rev Respir Dis. 1989 Jun;139(6):1361-8.

PMID:
2524981
44.

Use of a Chlamydia trachomatis DNA probe for detection of ocular chlamydiae.

Dean D, Palmer L, Pant CR, Courtright P, Falkow S, O'Hanley P.

J Clin Microbiol. 1989 May;27(5):1062-7.

46.

Complement levels in septic primates treated with anti-C5a antibodies.

Hangen DH, Stevens JH, Satoh PS, Hall EW, O'Hanley PT, Raffin TA.

J Surg Res. 1989 Mar;46(3):195-9.

PMID:
2493531
47.

Enhanced cell-mediated protection against fatal Escherichia coli septicemia induced by treatment with recombinant IL-2.

Goronzy J, Weyand C, Quan J, Fathman CG, O'Hanley P.

J Immunol. 1989 Feb 15;142(4):1134-8.

PMID:
2644349
48.

Attenuation of acute lung injury in septic guinea pigs by pentoxifylline.

Ishizaka A, Wu ZH, Stephens KE, Harada H, Hogue RS, O'Hanley PT, Raffin TA.

Am Rev Respir Dis. 1988 Aug;138(2):376-82.

PMID:
3057964
49.

Pulmonary edema after Escherichia coli peritonitis correlates with thiobarbituric-acid-reactive materials in bronchoalveolar lavage fluid.

Ishizaka A, Stephens KE, Tazelaar HD, Hall EW, O'Hanley P, Raffin TA.

Am Rev Respir Dis. 1988 Apr;137(4):783-9.

PMID:
3281528
50.

Supplemental Content

Loading ...
Support Center